摘要
恶性黑色素瘤是恶性程度高的肿瘤,其预后差,尤其是转移性的恶性黑色素瘤仍较难治疗。达卡巴嗪已不再显示其优越性。随着近年来对恶性黑色素瘤的深入研究,新的化疗药物、免疫、靶向药物治疗显示出了好的应用前景。
Melanoma melanoma is a kind of high degree of malignancy tumor,and has poor prognosis. Specifically metastatic melanoma remains a difficult disease to treat. Dacarbazine no longer shows its superiority. In recent years,with the further study of malignant melanoma,new chemotherapy drugs,targeted therapy and immune therapy show good prospect.
出处
《中国实用医刊》
2014年第11期82-84,共3页
Chinese Journal of Practical Medicine
关键词
恶性黑色素瘤
化疗
治疗现状
Malignant melanoma
Chemotherapy
Treatment status quo